Latest News
-
SAN DIEGO – The editors of Nature Biotechnology recently published an editorial entitled “Ultra-precision medicine” in the June 2021 issue of Nature Biotechnology[i], highlighting new initiatives in n-of-1 drug development, as well as the rapid progress that n-Lorem Foundation, a nonprofit organization providing the ultra-rare disease community with free, lifetime supplies... -
PHOENIX – OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, has extended its intellectual property (IP) portfolio to include an exclusive option to license IP rights for the use and delivery of myxoma virus to treat certain cancers from the University of Florida Research Foundation (UFRF). This IP was developed by...
-
Extended induction chemotherapy with topotecan, cyclophosphamide, and etoposide does not improve event-free survival (EFS) and overall survival (OS) in patients with high-risk neuroblastoma, and it increases the number of toxic side effects, according to findings published in the Annals of Oncology. The open-label, prospective, randomized controlled phase 3 NB2004-HR trial (ClinicalTrials.gov...
Videos
Rare disease spotlight
@KathyConWom Whether they are vaccinated or not they can still catch and spread the virus. So why are they so desperate to vaccinate everyone ?
@JuliaHB1 The secret to stop this madness is STOP getting tested, you only fuelling numbers and causing restrictions. Feel ok? Live your life. Not feeling ok? Stay home till you get better. Don’t need a test to tell you that you’re sick!
